Read + Share
Cakmak ME. Comparison of the Patients with Chronic Urticaria Who Responded and Did Not
Respond to Omalizumab Treatment: A Single-Center Retrospective Study. Int Arch Allergy Immunol 2022;183:1209-1215.
PMID: 36007494
|
 |
|
Cakmak ME. Comparison of the Patients with Chronic Urticaria Who Responded and Did Not
Respond to Omalizumab Treatment: A Single-Center Retrospective Study. Int Arch Allergy Immunol 2022;183:1209-1215.
PMID: 36007494
|
|
|
|